Literature DB >> 32241223

Catecholamines Induce Trained Immunity in Monocytes In Vitro and In Vivo.

Charlotte D C C van der Heijden1,2, Laszlo Groh1,2, Samuel T Keating1,2,3, Charlotte Kaffa4, Marlies P Noz1,2, Simone Kersten1,2, Antonius E van Herwaarden5, Alexander Hoischen2,3, Leo A B Joosten1,2,6, Henri J L M Timmers1, Mihai G Netea1,2,7, Niels P Riksen1,2.   

Abstract

RATIONALE: Exposure to high catecholamine levels is associated with inflammatory changes of myeloid cells and atherosclerosis, but the underlying mechanisms are only partly understood.
OBJECTIVE: To investigate whether the proinflammatory effects of noradrenaline and adrenaline can, in part, be explained by the induction of an immunologic memory in innate immune cells, termed trained immunity. METHODS AND
RESULTS: In vitro, we exposed human primary monocytes to (nor)adrenaline for 24 hours, after which cells were rested and differentiated to macrophages over 5 days. After restimulation with lipopolysaccharide on day 6, (nor)adrenaline-exposed cells showed increased TNF-α (tumor necrosis factor-α) production. This coincided with an increase in glycolysis and oxidative phosphorylation measured with Seahorse technology on day 6 before restimulation. Inhibition of the β-adrenoreceptor-cAMP signaling pathway prevented the induction of training. In vivo, we studied the functional, transcriptional, and epigenetic impact of peak-wise exposure to high catecholamine levels on monocytes isolated from pheochromocytoma/paraganglioma (PHEO) patients. In PHEO patients (n=10), the peripheral blood cell composition showed a myeloid bias and an increase of the inflammatory CD14++CD16+ (cluster of differentiation) intermediate monocyte subset compared with controls with essential hypertension (n=14). Ex vivo production of proinflammatory cytokines was higher in PHEO patients. These inflammatory changes persisted for 4 weeks after surgical removal of PHEO. Transcriptome analysis of circulating monocytes at baseline showed various differentially expressed genes in inflammatory pathways in PHEO patients; epigenetic profiling of the promoters of these genes suggests enrichment of the transcriptionally permissive chromatin mark H3K4me3 (trimethylation of lysine 4 on histone H3), indicative of in vivo training.
CONCLUSIONS: Catecholamines induce long-lasting proinflammatory changes in monocytes in vitro and in vivo, indicating trained immunity. Our data contribute to the understanding of pathways driving inflammatory changes in conditions characterized by high catecholamine levels and propose that trained immunity underlies the increased cardiovascular event rate in PHEO patients.

Entities:  

Keywords:  catecholamines; epinephrine; inflammation; innate immune system; norepinephrine; pheochromocytoma

Mesh:

Substances:

Year:  2020        PMID: 32241223     DOI: 10.1161/CIRCRESAHA.119.315800

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  25 in total

Review 1.  Novel roles of immunometabolism and nonmyocyte metabolism in cardiac remodeling and injury.

Authors:  Alan J Mouton; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-09-02       Impact factor: 3.619

2.  Recent Advances in GPCR-Regulated Leukocyte Responses during Acute Cardiac Injury.

Authors:  Tapas K Nayak; Douglas G Tilley
Journal:  Curr Opin Physiol       Date:  2020-09-15

3.  Role of the hematopoietic stem cells in immunological memory.

Authors:  Vinothini Govindarajah; Damien Reynaud
Journal:  Curr Stem Cell Rep       Date:  2022-01-07

Review 4.  Trained Immunity as a Trigger for Atherosclerotic Cardiovascular Disease-A Literature Review.

Authors:  Natalia Anna Zieleniewska; Małgorzata Kazberuk; Małgorzata Chlabicz; Andrzej Eljaszewicz; Karol Kamiński
Journal:  J Clin Med       Date:  2022-06-12       Impact factor: 4.964

5.  Reprogramming of bone marrow myeloid progenitor cells in patients with severe coronary artery disease.

Authors:  Marlies P Noz; Siroon Bekkering; Laszlo Groh; Tim Mj Nielen; Evert Jp Lamfers; Andreas Schlitzer; Saloua El Messaoudi; Niels van Royen; Erik Hjpg Huys; Frank Wmb Preijers; Esther Mm Smeets; Erik Hjg Aarntzen; Bowen Zhang; Yang Li; Manita Ej Bremmers; Walter Jfm van der Velden; Harry Dolstra; Leo Ab Joosten; Marc E Gomes; Mihai G Netea; Niels P Riksen
Journal:  Elife       Date:  2020-11-10       Impact factor: 8.140

6.  Adversity in early life and pregnancy are immunologically distinct from total life adversity: macrophage-associated phenotypes in women exposed to interpersonal violence.

Authors:  Kirstin Aschbacher; Melissa Hagan; Iris M Steine; Luisa Rivera; Steve Cole; Alyssa Baccarella; Elissa S Epel; Alicia Lieberman; Nicole R Bush
Journal:  Transl Psychiatry       Date:  2021-07-20       Impact factor: 6.222

Review 7.  Recent Advances in Studies on the Role of Neuroendocrine Disorders in Obstructive Sleep Apnea-Hypopnea Syndrome-Related Atherosclerosis.

Authors:  Wanda Wang; Yanli Zheng; Meimei Li; Shu Lin; Huili Lin
Journal:  Nat Sci Sleep       Date:  2021-07-27

8.  oxLDL-Induced Trained Immunity Is Dependent on Mitochondrial Metabolic Reprogramming.

Authors:  Laszlo A Groh; Anaisa V Ferreira; Leonie Helder; Charlotte D C C van der Heijden; Boris Novakovic; Els van de Westerlo; Vasiliki Matzaraki; Simone J C F M Moorlag; L Charlotte de Bree; Valerie A C M Koeken; Vera P Mourits; Samuel T Keating; Jelmer H van Puffelen; Alexander Hoischen; Leo A B Joosten; Mihai G Netea; Werner J H Koopman; Niels P Riksen
Journal:  Immunometabolism       Date:  2021-06-30

Review 9.  Immunometabolic control of trained immunity.

Authors:  Niels P Riksen; Mihai G Netea
Journal:  Mol Aspects Med       Date:  2020-09-02

10.  Type 2 MI induced by a single high dose of isoproterenol in C57BL/6J mice triggers a persistent adaptive immune response against the heart.

Authors:  Elvira Forte; Mona Panahi; Nicoleta Baxan; Fu Siong Ng; Joseph J Boyle; Jane Branca; Olivia Bedard; Muneer G Hasham; Lindsay Benson; Sian E Harding; Nadia Rosenthal; Susanne Sattler
Journal:  J Cell Mol Med       Date:  2020-11-29       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.